Excerpt:“…happening concurrently, said Shifara Samsudeen, an analyst at LightStream Research who publishes on the SMARTKARMA platform. The company, which produces drugs used in cancer treatment products, is a unit of Hong Kong-listed pharmaceutical company…”
Bloomberg First Word” itemscope=”itemscope” itemprop=”StoryLink”>here for a curated First Word channel of actionable news from Bloomberg and select sources. It can be customized to your preferences by clicking into Actions on the toolbar or hitting the HELP key for assistance.
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.
Bloomberg First Word” itemscope=”itemscope” itemprop=”StoryLink”>here for a curated First Word channel of actionable news from Bloomberg and select sources. It can be customized to your preferences by clicking into Actions on the toolbar or hitting the HELP key for assistance.
